TickerFacts.

Baxter International Inc (BAX): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.97B
As of 2025-12-31
$2.15B
As of 2026-06-30
+6.6%
3-year compound annual growth
$3.73B2007-12-31: $2.54B2008-12-31: $2.13B2009-12-31: $2.79B2010-12-31: $2.69B2011-12-31: $2.90B2012-12-31: $3.27B2013-12-31: $2.73B2014-12-31: $2.92B2015-12-31: $2.21B2016-12-31: $2.80B2017-12-31: $3.39B2018-03-31: $2.95B2018-06-30: $2.86B2018-09-30: $2.86B2018-12-31: $1.84B2019-03-31: $1.90B2019-06-30: $2.93B2019-12-31: $3.33B2020-12-31: $3.73B2021-12-31: $2.95B2022-12-31: $1.62B2023-12-31: $3.08B2024-12-31: $1.76B2025-12-31: $1.97B$1.97B
2007-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.97B+11.5%2026-02-12, Balance as of period end
2024-12-31$1.76B-42.7%2026-02-12, Balance as of period end
2023-12-31$3.08B+89.9%2026-02-12, Balance as of period end
2022-12-31$1.62Bn/c2025-02-21, Balance as of period end
2021-12-31$2.95B-20.9%2024-02-08, Balance as of period end
2020-12-31$3.73B+11.8%2023-02-09, Balance as of period end
2019-12-31$3.33Bn/a2021-02-11, Balance as of period end
2019-06-30$2.93Bn/a2020-03-17, Balance as of period end
2019-03-31$1.90Bn/a2020-03-17, Balance as of period end
2018-12-31$1.84Bn/a2020-03-17, Balance as of period end
2018-09-30$2.86Bn/a2020-03-17, Balance as of period end
2018-06-30$2.86Bn/a2020-03-17, Balance as of period end
2018-03-31$2.95Bn/a2020-03-17, Balance as of period end
2017-12-31$3.39B+21.2%2019-02-21, Balance as of period end
2016-12-31$2.80B+26.6%2019-02-21, Balance as of period end
2015-12-31$2.21B-24.3%2018-02-23, Balance as of period end
2014-12-31$2.92B+7.0%2017-02-23, Balance as of period end
2013-12-31$2.73B-16.4%2016-02-26, Balance as of period end
2012-12-31$3.27B+12.6%2015-02-26, Balance as of period end
2011-12-31$2.90B+8.2%2014-02-21, Balance as of period end
2010-12-31$2.69B-3.6%2013-02-21, Balance as of period end
2009-12-31$2.79B+30.7%2012-02-23, Balance as of period end
2008-12-31$2.13B-16.1%2011-02-23, Balance as of period end
2007-12-31$2.54Bn/a2010-02-23, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
Solventum Corp (SOLV)2025-12-31$878.00M+15.2%
Boston Scientific Corp (BSX)2025-12-31$1.97B+374.6%
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
ResMed Inc (RMD)2026-06-30$1.47B+21.5%
Stryker Corp (SYK)2025-12-31$4.01B+9.8%
Dexcom Inc (DXCM)2025-12-31$917.70M+51.4%
Medline Inc. (MDLN)2025-12-31$1.94B+874.4%
MiniMed Group, Inc. (MMED)2026-04-24$298.00Mn/m

Compare BAX, SOLV, BSX, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗